Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + Yervoy
nivolumab + ipilimumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
As first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma.
LAMPGEN ANALYSIS
Why it matters
CheckMate 9DW supported moving combined PD-1 and CTLA-4 blockade into the first-line liver cancer setting.
What research teams should watch
Prespecify how sites will document baseline liver function and evaluate changes that could reflect either treatment toxicity or underlying liver disease.
PRIMARY RECORDS